There were no reported adverse effects and it was confirmed that GLP-1 prevented the diabetogenic effect of glucagon through its insulinotropic actions
Cardiovasc Diabetol 20:32 Hundertmark MJ, Agbaje OF, Coleman R, George JT, Grempler R, Holman RR, Lamlum H, Lee J, Milton JE, Niessen HG, Rider O, Rodgers CT, Valkovi L, Wicks E, Mahmod M, Neubauer S (2021) Design and rationale of the EMPA-VISION trial: investigating the metabolic effects of empagliflozin in patients with heart failure
Biosens Bioelectron 179(1):113052 Meca AD, Turcu-Stiolica A, Stanciulescu EC, Andrei AM, Nitu FM, Banita IM, Matei M, Pisoschi CG (2021) Variations of serum oxidative stress biomarkers under first-line antituberculosis treatment: A pilot study
In the context of obesity-related inflammation, adipose tissue macrophages isolated from obese mice and humans often exhibit increased de novo PC biosynthesis (71)
But drug manufacturers and researchers recognize the perks of pills